Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on October 3, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Studies, Reports, and Activities Relevant to Biomedical Sciences

Closed
HHS-NIH-OD-OLAO-OA-SS-23-272Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

N/A

Place of Performance

MD, 20852, USA

Set-Aside

NONE

Documents

1

NIH Studies, Reports, and Activities Relevant to Biomedical Sciences SOW

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates
PhaseClosed
Posted

Sources Sought

Deadline changed

Response deadline changed from Oct 16, 2023 to Oct 23, 2023.

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
This is a Sources Sought notice. This is NOT a solicitation for proposals. The National Institutes of Health (NIH), Office of Science Policy (OSP), is initiating this sources sought as a step in NIH's market survey for potential contractors to provide NIH with high-level, executive studies, reports, analyses, reviews, assessments, evaluations, surveys, conferences, symposia, or workshops (held as in-person and/or virtual at the Contractor's location) critical to the mission of the NIH. Potential contracts shall drawing upon the scientific and technical expertise as well as that of other representatives of the scientific community to perform specific tasks. Each task will be accomplished as a task order under an IDIQ using an RFQ process which will require a cost and technical proposal.as long as NIH has approved the general approach via the execution of a task order. The Contractor shall demonstrate their unique capability to perform the work. The Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities needed to perform the work enumerated below using this Task Order approach: a. In-depth studies, which may focus on either issues of topical interest or long-range concerns of the biomedical sciences research community, and program reviews, and will result in independent, specific findings supporting recommendations to the NIH. b. The contractor shall have the experience and expertise with Congressional tasks, directives and reviews. c. Conduct NIH Policy reviews, and the study of the ethical and legal issues of biomedical sciences research. Such reviews may be either general, covering a broad area of biomedical/behavioral interest, or they may address more narrowly defined issues of relevance to the NIH. d. Evaluation studies and program assessments. Evaluation efforts will generally focus on, but not be limited to, assessments of ongoing NIH programs, processes, or activities. e. Surveys on topics of specific interest to the NIH. Survey participants could include recognized members of the biomedical/behavioral community, universities, research institutions, and other elements of the scientific community. f. Conferences, symposia, seminars, or workshops on either a general area of interest or specific issues of concern to the NIH. Such events would result in a high-level written report with recommendations authored without interference and independent of undue influence of outside parties. g. Convening of committees that meet regularly to discuss various biomedical sciences research NIH initiates with the purpose of determining outcomes and/or recommendations to NIH. These groups would be comprised of the foremost academic, industry, non-profit, and governmental experts in the topic area. Respondents shall demonstrate the ability to successfully conduct large-scale tasks for studies/projects simultaneously and produce printed and published deliverables (Section 508 compliant) such as workshop summaries and high-level final committee consensus reports. The respondent must demonstrate and provide concrete experience to convene committees of 12-20 industry experts with varied expertise for the study topic resulting in expert, high-level reports. The respondent must demonstrate that they are experts in providing top customer service, possess strong and clear communication, can support a large capacity of tasks, be able to maintain independence, can have the ability to recruit top scientists and clinicians who are internationally recognized in their field. The respondent must be able to recruit top world-renowned expert scientists and clinicians in government and industry in the biomedical science and technology fields for each of these studies/projects. The contractor shall be recognized for its independence from university, government, and industry influence above all else. The respondent must be able to outline and detail their conflict-of-interest policy and procedures and how their reports are vetted. The respondent must demonstrate and detail how they maintain their confidentiality and their independence from outside influences. *A committee is defined as a group of experts called on by the respondent to be on a committee during the period of performance of the task. Committee members are not contractor's employees or subcontractors and independent of the contractor's organization or affiliates. The committee members shall develop an independent report regarding the topic. The North American Industry Classification System (NAICS) for this requirement is 541690 with a size standard of $19.0 million. Considering this project summary, all interested concerns are invited to submit a tailored capability statement. The government requests that no proprietary or confidential business data be submitted in a response to this notice. Capability statements must include the name and telephone numbers of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation or responses to an incorrect NAICS code will not be considered. The capability statement should reference Sources Sought Number HHS-NIH-OD-OLAO-OA-SS-23-272 and should be no longer than 14 single sided or 7 double sided pages in length with a 12-point font size in PDF format and shall include the following: (1) Name and Address of the Organization, (2) Size and type of business pursuant to the applicable NAICS code 541690, Point of Contact with name, title, phone, and email, (4) UEI number, (5) Contractor's capability statement that addresses the organization's ability, knowledge, experience, and personnel to perform the services described as above. (Pamphlets and standard brochures will not be considered responsive to this Sources Sought Notice.) (6) List of three organizations which equivalent types of services have been previously provided within the last three years - to include contract number, dollar value, and name, telephone number and email of the customer. This market survey is being conducted to reach the widest possible audience and to gather current market information. ALL INFORMATION SUBMITTED IN RESPONSE TO THIS ANNOUNCEMENT MUST BE RECEIVED ON OR BEFORE THE CLOSING DATE. THE CLOSING DATE FOR RESPONSES IS 16 October, 2023 @ 5:00 PM EDT. Please Email virus free capability statements in PDF format to mary.taneyhill@nih.gov. Comments and questions will NOT be answered but may assist in creating a solicitation for this procurement. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be listed in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325411
New
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 14 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS